Engineering Tumour Cell-Binding Synthetic Polymers with Sensing Dense Transporters Associated with Aberrant Glutamine Metabolism
Increased glutamine uptake toward the elevated glutaminolysis is one of the hallmarks of tumour cells. This aberrant glutamine metabolism has recently attracted considerable attention as a diagnostic and therapeutic target. Herein, we developed glutamine-functionalized polymer to achieve a selective...
Saved in:
| Published in | Scientific reports Vol. 7; no. 1; pp. 6077 - 10 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
20.07.2017
Nature Publishing Group Nature Portfolio |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2045-2322 2045-2322 |
| DOI | 10.1038/s41598-017-06438-y |
Cover
| Abstract | Increased glutamine uptake toward the elevated glutaminolysis is one of the hallmarks of tumour cells. This aberrant glutamine metabolism has recently attracted considerable attention as a diagnostic and therapeutic target. Herein, we developed glutamine-functionalized polymer to achieve a selective high affinity to tumour cells overexpressing glutaminolysis-related transporter ASCT2. In
in vitro
study, our developed polymer exhibited faster and higher cellular uptake in tumour cells than that in normal cells. Uptake inhibition study revealed the dominant contribution of ASCT2 to the polymer-cell interaction. Furthermore, the binding affinity of the polymer to tumour cells was estimated to be comparable to that of the potent ligand molecules reported in the literature. In
in vivo
study, the polymer showed prolonged retention at tumour site after intratumoral injection. This study offers a novel approach for designing tumour cell-binding synthetic polymers through the recognition of dense transporters related to tumour-associated metabolism. |
|---|---|
| AbstractList | Increased glutamine uptake toward the elevated glutaminolysis is one of the hallmarks of tumour cells. This aberrant glutamine metabolism has recently attracted considerable attention as a diagnostic and therapeutic target. Herein, we developed glutamine-functionalized polymer to achieve a selective high affinity to tumour cells overexpressing glutaminolysis-related transporter ASCT2. In
in vitro
study, our developed polymer exhibited faster and higher cellular uptake in tumour cells than that in normal cells. Uptake inhibition study revealed the dominant contribution of ASCT2 to the polymer-cell interaction. Furthermore, the binding affinity of the polymer to tumour cells was estimated to be comparable to that of the potent ligand molecules reported in the literature. In
in vivo
study, the polymer showed prolonged retention at tumour site after intratumoral injection. This study offers a novel approach for designing tumour cell-binding synthetic polymers through the recognition of dense transporters related to tumour-associated metabolism. Increased glutamine uptake toward the elevated glutaminolysis is one of the hallmarks of tumour cells. This aberrant glutamine metabolism has recently attracted considerable attention as a diagnostic and therapeutic target. Herein, we developed glutamine-functionalized polymer to achieve a selective high affinity to tumour cells overexpressing glutaminolysis-related transporter ASCT2. In in vitro study, our developed polymer exhibited faster and higher cellular uptake in tumour cells than that in normal cells. Uptake inhibition study revealed the dominant contribution of ASCT2 to the polymer-cell interaction. Furthermore, the binding affinity of the polymer to tumour cells was estimated to be comparable to that of the potent ligand molecules reported in the literature. In in vivo study, the polymer showed prolonged retention at tumour site after intratumoral injection. This study offers a novel approach for designing tumour cell-binding synthetic polymers through the recognition of dense transporters related to tumour-associated metabolism. Increased glutamine uptake toward the elevated glutaminolysis is one of the hallmarks of tumour cells. This aberrant glutamine metabolism has recently attracted considerable attention as a diagnostic and therapeutic target. Herein, we developed glutamine-functionalized polymer to achieve a selective high affinity to tumour cells overexpressing glutaminolysis-related transporter ASCT2. In in vitro study, our developed polymer exhibited faster and higher cellular uptake in tumour cells than that in normal cells. Uptake inhibition study revealed the dominant contribution of ASCT2 to the polymer-cell interaction. Furthermore, the binding affinity of the polymer to tumour cells was estimated to be comparable to that of the potent ligand molecules reported in the literature. In in vivo study, the polymer showed prolonged retention at tumour site after intratumoral injection. This study offers a novel approach for designing tumour cell-binding synthetic polymers through the recognition of dense transporters related to tumour-associated metabolism.Increased glutamine uptake toward the elevated glutaminolysis is one of the hallmarks of tumour cells. This aberrant glutamine metabolism has recently attracted considerable attention as a diagnostic and therapeutic target. Herein, we developed glutamine-functionalized polymer to achieve a selective high affinity to tumour cells overexpressing glutaminolysis-related transporter ASCT2. In in vitro study, our developed polymer exhibited faster and higher cellular uptake in tumour cells than that in normal cells. Uptake inhibition study revealed the dominant contribution of ASCT2 to the polymer-cell interaction. Furthermore, the binding affinity of the polymer to tumour cells was estimated to be comparable to that of the potent ligand molecules reported in the literature. In in vivo study, the polymer showed prolonged retention at tumour site after intratumoral injection. This study offers a novel approach for designing tumour cell-binding synthetic polymers through the recognition of dense transporters related to tumour-associated metabolism. Abstract Increased glutamine uptake toward the elevated glutaminolysis is one of the hallmarks of tumour cells. This aberrant glutamine metabolism has recently attracted considerable attention as a diagnostic and therapeutic target. Herein, we developed glutamine-functionalized polymer to achieve a selective high affinity to tumour cells overexpressing glutaminolysis-related transporter ASCT2. In in vitro study, our developed polymer exhibited faster and higher cellular uptake in tumour cells than that in normal cells. Uptake inhibition study revealed the dominant contribution of ASCT2 to the polymer-cell interaction. Furthermore, the binding affinity of the polymer to tumour cells was estimated to be comparable to that of the potent ligand molecules reported in the literature. In in vivo study, the polymer showed prolonged retention at tumour site after intratumoral injection. This study offers a novel approach for designing tumour cell-binding synthetic polymers through the recognition of dense transporters related to tumour-associated metabolism. |
| ArticleNumber | 6077 |
| Author | Nomoto, Takahiro Mori, Masaki Nishiyama, Nobuhiro Tomoda, Keishiro Takemoto, Hiroyasu Yamada, Naoki Honda, Yuto Ishii, Hideshi Matsui, Makoto Konno, Masamitsu |
| Author_xml | – sequence: 1 givenname: Naoki surname: Yamada fullname: Yamada, Naoki organization: Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology – sequence: 2 givenname: Yuto surname: Honda fullname: Honda, Yuto organization: Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology – sequence: 3 givenname: Hiroyasu surname: Takemoto fullname: Takemoto, Hiroyasu organization: Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology – sequence: 4 givenname: Takahiro surname: Nomoto fullname: Nomoto, Takahiro organization: Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology – sequence: 5 givenname: Makoto surname: Matsui fullname: Matsui, Makoto organization: Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology – sequence: 6 givenname: Keishiro surname: Tomoda fullname: Tomoda, Keishiro organization: Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology – sequence: 7 givenname: Masamitsu surname: Konno fullname: Konno, Masamitsu organization: Graduate School of Medicine, Department of Gastroenterological Surgery, Osaka University – sequence: 8 givenname: Hideshi surname: Ishii fullname: Ishii, Hideshi organization: Graduate School of Medicine, Department of Gastroenterological Surgery, Osaka University – sequence: 9 givenname: Masaki surname: Mori fullname: Mori, Masaki organization: Graduate School of Medicine, Department of Gastroenterological Surgery, Osaka University – sequence: 10 givenname: Nobuhiro surname: Nishiyama fullname: Nishiyama, Nobuhiro email: nishiyama.n.ad@m.titech.ac.jp organization: Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, Innovation Center of Nanomedicine (iCONM), Kawasaki Institute of Industrial Promotion |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28729677$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9Uk1v1DAQjVARLaV_gAOKxIVLwHb8EV-QylJKpSKQupwtf2XXq8RebAe0N346TrdU20rgy1gz7z3PjN_z6sgHb6vqJQRvIWi7dwlDwrsGQNYAituu2T2pThDApEEtQkcH9-PqLKUNKIcgjiF_Vh2jjiFOGTupfl_4lfPWRudX9XIawxTrhR2G5oPzZs7d7Hxe2-x0_S0Mu9HGVP9yeV3fWJ_m-scSbb2M0qdtiHmun6cUtJPZmj30XNlY6rm-HKYsx_Jc_cVmqcLg0viietrLIdmzu3haff90sVx8bq6_Xl4tzq8bTTqcGyR7BYjWmgAEFLC9pLzVRHdYI0wkY4YBjI3ifYuN7vsWUWO4tqxlFEqq29Pqaq9rgtyIbXSjjDsRpBO3iRBXQsYy5mAFpUQB1SqpWIc57hTFsDPKWKUNJL0qWu_3WttJjdZo63OUwwPRhxXv1mIVfgpCIKecFYE3dwIx_JhsymJ0SZe1S2_DlATkCBFAOwoL9PUj6Kb8kS-rKihCIWspBwX16rCj-1b-fnQBoD1Ax5BStP09BAIxG0rsDSWKocStocSukLpHJO2yzC7MU7nh_9R2T03b2Vo2HrT9b9YfdTDjwA |
| CitedBy_id | crossref_primary_10_1002_marc_202400623 crossref_primary_10_1016_j_jconrel_2024_11_017 crossref_primary_10_1038_s41428_023_00793_6 crossref_primary_10_1021_acs_biomac_2c00803 crossref_primary_10_1038_s41428_023_00774_9 crossref_primary_10_1126_sciadv_aaz1722 crossref_primary_10_1038_s41428_021_00542_7 crossref_primary_10_1021_acs_biomac_4c01591 crossref_primary_10_1021_acs_nanolett_4c03334 crossref_primary_10_1002_marc_202100615 crossref_primary_10_1021_acs_biomac_4c01061 crossref_primary_10_1038_s41388_018_0406_x crossref_primary_10_1002_cnma_202300324 crossref_primary_10_1016_j_biomaterials_2022_121987 crossref_primary_10_1021_acsabm_1c00771 crossref_primary_10_1021_acs_biomac_2c00143 crossref_primary_10_1016_j_bioactmat_2023_01_005 crossref_primary_10_1016_j_jconrel_2017_09_005 crossref_primary_10_3390_ijms19061646 |
| Cites_doi | 10.1126/science.1160809 10.1021/ja972089n 10.1074/jbc.271.25.14883 10.1002/path.4518 10.1007/s00424-003-1117-9 10.1038/nrd4145 10.1074/jbc.274.28.19745 10.1038/nature12040 10.1038/onc.2015.381 10.1006/bbrc.2001.4504 10.1126/scitranslmed.aaa1009 10.1074/jbc.M002965200 10.1113/jphysiol.2004.062521 10.1016/S0005-2736(01)00384-4 10.1002/ijc.28749 10.1042/BJ20040487 10.1021/ar900035f 10.4155/tde.12.165 10.1111/cas.12602 10.1038/onc.2015.447 10.5935/MedicalExpress.2016.06.05 10.1016/j.bmcl.2014.10.098 10.1038/nrc2981 10.1021/bm100248e 10.1016/j.bmc.2004.11.028 10.1021/cb400258d 10.1021/mp500236y 10.1021/ja411138s 10.2967/jnumed.111.101279 10.1038/nrd4519 10.1007/s00726-014-1808-x 10.1002/cbic.201600023 10.1016/0006-2952(73)90196-2 10.2967/jnumed.112.103069 10.1046/j.1471-4159.1999.02184.x 10.1152/ajpgi.00031.2002 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2017 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2017 – notice: 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
| DOI | 10.1038/s41598-017-06438-y |
| DatabaseName | SpringerOpen CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Medical Database Science Database Biological science database Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | CrossRef Publicly Available Content Database MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2045-2322 |
| EndPage | 10 |
| ExternalDocumentID | oai_doaj_org_article_665b0b3bab784948b6418dbdebcd15fb PMC5519697 28729677 10_1038_s41598_017_06438_y |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS EJD ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT NPM 7XB 8FK AARCD K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c584t-2afb05ccc5020b0efa693c5c84c245a77d7044db9f34dcff326dd9ce73761a6c3 |
| IEDL.DBID | M48 |
| ISSN | 2045-2322 |
| IngestDate | Wed Aug 27 01:31:12 EDT 2025 Thu Aug 21 18:12:43 EDT 2025 Thu Sep 04 15:09:22 EDT 2025 Wed Aug 13 10:59:19 EDT 2025 Thu Apr 03 07:09:36 EDT 2025 Thu Apr 24 23:00:15 EDT 2025 Tue Jul 01 01:33:20 EDT 2025 Fri Feb 21 02:40:18 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c584t-2afb05ccc5020b0efa693c5c84c245a77d7044db9f34dcff326dd9ce73761a6c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-017-06438-y |
| PMID | 28729677 |
| PQID | 1956173690 |
| PQPubID | 2041939 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_665b0b3bab784948b6418dbdebcd15fb pubmedcentral_primary_oai_pubmedcentral_nih_gov_5519697 proquest_miscellaneous_1922506861 proquest_journals_1956173690 pubmed_primary_28729677 crossref_primary_10_1038_s41598_017_06438_y crossref_citationtrail_10_1038_s41598_017_06438_y springer_journals_10_1038_s41598_017_06438_y |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2017-07-20 |
| PublicationDateYYYYMMDD | 2017-07-20 |
| PublicationDate_xml | – month: 07 year: 2017 text: 2017-07-20 day: 20 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Scientific reports |
| PublicationTitleAbbrev | Sci Rep |
| PublicationTitleAlternate | Sci Rep |
| PublicationYear | 2017 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | Silpe (CR16) 2013; 8 Fox, Szoka, Fréchet (CR38) 2009; 42 Yanagida (CR27) 2001; 1514 Srinivasarao, Galliford, Low (CR13) 2015; 14 Rautio, Gynther, Laine (CR32) 2013; 4 Bode (CR6) 2002; 283 CR36 Nakanishi (CR37) 2001; 281 Dubacheva (CR15) 2014; 136 Esslinger, Cybulski, Rhoderick (CR17) 2005; 13 Utsunomiya-Tate, Endou, Kanai (CR23) 1996; 271 Vander Heiden, Cantley, Thompson (CR3) 2009; 324 Cairns, Harris, Mak (CR1) 2011; 11 Mackenzie, Erickson (CR25) 2004; 447 Ploessl, Wang, Lieberman, Qu, Kung (CR31) 2012; 53 Jin, Alesi, Kang (CR4) 2016; 35 Wang (CR9) 2014; 135 Yao (CR26) 2000; 275 Venneti (CR10) 2015; 7 Scalise (CR12) 2014; 46 Wu (CR11) 2014; 11 Wang (CR7) 2015; 236 Wang, Dormidontova (CR14) 2010; 11 Monestier (CR30) 2016; 17 Wang, Holst (CR33) 2015; 5 Bungard, McGivan (CR20) 2004; 382 Bröer (CR22) 1999; 73 Wiriyasermkul (CR35) 2012; 53 Galluzzi, Kepp, Vander Heiden, Kroemer (CR2) 2013; 12 Schulte, Dawson, Saleh, Cuthbertson, Manning (CR24) 2015; 25 Alves, Uno, da Silva, Oba-Shinjo, Marie (CR19) 2016; 3 Yung-Chi, Prusoff (CR39) 1973; 22 Huang (CR18) 2014; 7 Grewer, Grabsch (CR29) 2004; 557 Kanai, Mortell, Kiessling (CR21) 1997; 119 Segawa (CR28) 1999; 274 van Geldermalsen (CR8) 2016; 35 Son (CR5) 2013; 496 Wongthai (CR34) 2015; 106 Q Wang (6438_CR33) 2015; 5 M Scalise (6438_CR12) 2014; 46 GV Dubacheva (6438_CR15) 2014; 136 P Wiriyasermkul (6438_CR35) 2012; 53 M van Geldermalsen (6438_CR8) 2016; 35 CS Esslinger (6438_CR17) 2005; 13 M Srinivasarao (6438_CR13) 2015; 14 C Grewer (6438_CR29) 2004; 557 MG Vander Heiden (6438_CR3) 2009; 324 Q Wang (6438_CR7) 2015; 236 MJF Alves (6438_CR19) 2016; 3 CI Bungard (6438_CR20) 2004; 382 RA Cairns (6438_CR1) 2011; 11 ME Fox (6438_CR38) 2009; 42 O Yanagida (6438_CR27) 2001; 1514 Z Wu (6438_CR11) 2014; 11 K Ploessl (6438_CR31) 2012; 53 F Huang (6438_CR18) 2014; 7 6438_CR36 S Venneti (6438_CR10) 2015; 7 D Yao (6438_CR26) 2000; 275 H Segawa (6438_CR28) 1999; 274 BP Bode (6438_CR6) 2002; 283 L Galluzzi (6438_CR2) 2013; 12 JE Silpe (6438_CR16) 2013; 8 M Monestier (6438_CR30) 2016; 17 Q Wang (6438_CR9) 2014; 135 ML Schulte (6438_CR24) 2015; 25 C Yung-Chi (6438_CR39) 1973; 22 N Utsunomiya-Tate (6438_CR23) 1996; 271 S Wang (6438_CR14) 2010; 11 M Kanai (6438_CR21) 1997; 119 L Jin (6438_CR4) 2016; 35 J Rautio (6438_CR32) 2013; 4 J Son (6438_CR5) 2013; 496 A Bröer (6438_CR22) 1999; 73 T Nakanishi (6438_CR37) 2001; 281 P Wongthai (6438_CR34) 2015; 106 B Mackenzie (6438_CR25) 2004; 447 |
| References_xml | – volume: 324 start-page: 1029 year: 2009 end-page: 33 ident: CR3 article-title: Understanding the Warburg effect: the metabolic requirements of cell proliferation publication-title: Science (80-.) doi: 10.1126/science.1160809 – volume: 283 start-page: G1062 year: 2002 end-page: 73 ident: CR6 article-title: Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. – volume: 119 start-page: 9931 year: 1997 end-page: 9932 ident: CR21 article-title: Varying the Size of Multivalent Ligands: The Dependence of Concanavalin A Binding on Neoglycopolymer Length publication-title: J. Am. Chem. Soc. doi: 10.1021/ja972089n – volume: 271 start-page: 14883 year: 1996 end-page: 90 ident: CR23 article-title: Cloning and functional characterization of a system ASC-like Na + -dependent neutral amino acid transporter publication-title: J. Biol. Chem. doi: 10.1074/jbc.271.25.14883 – volume: 236 start-page: 278 year: 2015 end-page: 89 ident: CR7 article-title: Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development publication-title: J. Pathol. doi: 10.1002/path.4518 – volume: 447 start-page: 784 year: 2004 end-page: 95 ident: CR25 article-title: Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family publication-title: Pflugers Arch. doi: 10.1007/s00424-003-1117-9 – volume: 12 start-page: 829 year: 2013 end-page: 46 ident: CR2 article-title: Metabolic targets for cancer therapy publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4145 – volume: 274 start-page: 19745 year: 1999 end-page: 51 ident: CR28 article-title: Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity publication-title: J. Biol. Chem. doi: 10.1074/jbc.274.28.19745 – volume: 496 start-page: 101 year: 2013 end-page: 105 ident: CR5 article-title: Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway publication-title: Nature doi: 10.1038/nature12040 – volume: 35 start-page: 3201 year: 2016 end-page: 8 ident: CR8 article-title: ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer publication-title: Oncogene doi: 10.1038/onc.2015.381 – volume: 281 start-page: 1343 year: 2001 end-page: 1348 ident: CR37 article-title: Structure, Function, and Tissue Expression Pattern of Human SN2, a Subtype of the Amino Acid Transport System N publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.2001.4504 – volume: 7 start-page: 274ra17 year: 2015 end-page: 274ra17 ident: CR10 article-title: Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aaa1009 – volume: 275 start-page: 22790 year: 2000 end-page: 22797 ident: CR26 article-title: A Novel System A Isoform Mediating Na+/Neutral Amino Acid Cotransport publication-title: J. Biol. Chem. doi: 10.1074/jbc.M002965200 – volume: 557 start-page: 747 year: 2004 end-page: 759 ident: CR29 article-title: New inhibitors for the neutral amino acid transporter ASCT2 reveal its Na+-dependent anion leak publication-title: J. Physiol. doi: 10.1113/jphysiol.2004.062521 – volume: 1514 start-page: 291 year: 2001 end-page: 302 ident: CR27 article-title: Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines publication-title: Biochim. Biophys. Acta doi: 10.1016/S0005-2736(01)00384-4 – volume: 135 start-page: 1060 year: 2014 end-page: 71 ident: CR9 article-title: Targeting glutamine transport to suppress melanoma cell growth publication-title: Int. J. cancer doi: 10.1002/ijc.28749 – volume: 382 start-page: 27 year: 2004 end-page: 32 ident: CR20 article-title: Glutamine availability up-regulates expression of the amino acid transporter protein ASCT2 in HepG2 cells and stimulates the ASCT2 promoter publication-title: Biochem. J. doi: 10.1042/BJ20040487 – volume: 42 start-page: 1141 year: 2009 end-page: 1151 ident: CR38 article-title: Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular Architecture publication-title: Acc. Chem. Res. doi: 10.1021/ar900035f – volume: 73 start-page: 2184 year: 1999 end-page: 94 ident: CR22 article-title: The astroglial ASCT2 amino acid transporter as a mediator of glutamine efflux publication-title: J. Neurochem. – volume: 4 start-page: 281 year: 2013 end-page: 284 ident: CR32 article-title: LAT1-mediated prodrug uptake: a way to breach the blood–brain barrier? publication-title: Ther. Deliv. doi: 10.4155/tde.12.165 – volume: 5 start-page: 1281 year: 2015 end-page: 94 ident: CR33 article-title: L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia publication-title: Am. J. Cancer Res. – volume: 106 start-page: 279 year: 2015 end-page: 286 ident: CR34 article-title: Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB 0, +, LAT1 and LAT2 publication-title: Cancer Sci. doi: 10.1111/cas.12602 – volume: 35 start-page: 3619 year: 2016 end-page: 25 ident: CR4 article-title: Glutaminolysis as a target for cancer therapy publication-title: Oncogene doi: 10.1038/onc.2015.447 – volume: 3 start-page: 1 year: 2016 end-page: 8 ident: CR19 article-title: The expression of the aminoacid transporters ASCT2 (SLC1A5) and LAT1 (SLC7A5) in astrocytomas publication-title: Med. Express doi: 10.5935/MedicalExpress.2016.06.05 – volume: 25 start-page: 113 year: 2015 end-page: 116 ident: CR24 article-title: 2-Substituted Nγ-glutamylanilides as novel probes of ASCT2 with improved potency publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2014.10.098 – volume: 11 start-page: 85 year: 2011 end-page: 95 ident: CR1 article-title: Regulation of cancer cell metabolism publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2981 – volume: 11 start-page: 1785 year: 2010 end-page: 1795 ident: CR14 article-title: Nanoparticle Design Optimization for Enhanced Targeting: Monte Carlo Simulations publication-title: Biomacromolecules doi: 10.1021/bm100248e – volume: 13 start-page: 1111 year: 2005 end-page: 1118 ident: CR17 article-title: Nγ-Aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2004.11.028 – volume: 8 start-page: 2063 year: 2013 end-page: 2071 ident: CR16 article-title: Avidity Modulation of Folate-Targeted Multivalent Dendrimers for Evaluating Biophysical Models of Cancer Targeting Nanoparticles publication-title: ACS Chem. Biol. doi: 10.1021/cb400258d – volume: 11 start-page: 3852 year: 2014 end-page: 3866 ident: CR11 article-title: [18 F](2 S, 4 S)-4-(3-Fluoropropyl)glutamine as a Tumor Imaging Agent publication-title: Mol. Pharm. doi: 10.1021/mp500236y – volume: 136 start-page: 1722 year: 2014 end-page: 1725 ident: CR15 article-title: Superselective Targeting Using Multivalent Polymers publication-title: J. Am. Chem. Soc. doi: 10.1021/ja411138s – volume: 53 start-page: 1616 year: 2012 end-page: 1624 ident: CR31 article-title: Comparative Evaluation of 18F-Labeled Glutamic Acid and Glutamine as Tumor Metabolic Imaging Agents publication-title: J. Nucl. Med. doi: 10.2967/jnumed.111.101279 – volume: 14 start-page: 203 year: 2015 end-page: 219 ident: CR13 article-title: Principles in the design of ligand-targeted cancer therapeutics and imaging agents publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4519 – ident: CR36 – volume: 7 start-page: 6006 year: 2014 end-page: 6014 ident: CR18 article-title: Upregulated SLC1A5 promotes cell growth and survival in colorectal cancer publication-title: Int J Clin Exp Pathol – volume: 46 start-page: 2463 year: 2014 end-page: 2475 ident: CR12 article-title: Transport mechanism and regulatory properties of the human amino acid transporter ASCT2 (SLC1A5) publication-title: Amino Acids doi: 10.1007/s00726-014-1808-x – volume: 17 start-page: 590 year: 2016 end-page: 594 ident: CR30 article-title: ASGPR-Mediated Uptake of Multivalent Glycoconjugates for Drug Delivery in Hepatocytes publication-title: ChemBioChem doi: 10.1002/cbic.201600023 – volume: 22 start-page: 3099 year: 1973 end-page: 3108 ident: CR39 article-title: Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction publication-title: Biochem. Pharmacol. doi: 10.1016/0006-2952(73)90196-2 – volume: 53 start-page: 1253 year: 2012 end-page: 1261 ident: CR35 article-title: Transport of 3-Fluoro-L–Methyl-Tyrosine by Tumor-Upregulated L-Type Amino Acid Transporter 1: A Cause of the Tumor Uptake in PET publication-title: J. Nucl. Med. doi: 10.2967/jnumed.112.103069 – volume: 14 start-page: 203 year: 2015 ident: 6438_CR13 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4519 – volume: 274 start-page: 19745 year: 1999 ident: 6438_CR28 publication-title: J. Biol. Chem. doi: 10.1074/jbc.274.28.19745 – volume: 271 start-page: 14883 year: 1996 ident: 6438_CR23 publication-title: J. Biol. Chem. doi: 10.1074/jbc.271.25.14883 – volume: 11 start-page: 3852 year: 2014 ident: 6438_CR11 publication-title: Mol. Pharm. doi: 10.1021/mp500236y – volume: 35 start-page: 3619 year: 2016 ident: 6438_CR4 publication-title: Oncogene doi: 10.1038/onc.2015.447 – volume: 5 start-page: 1281 year: 2015 ident: 6438_CR33 publication-title: Am. J. Cancer Res. – volume: 281 start-page: 1343 year: 2001 ident: 6438_CR37 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.2001.4504 – volume: 17 start-page: 590 year: 2016 ident: 6438_CR30 publication-title: ChemBioChem doi: 10.1002/cbic.201600023 – volume: 12 start-page: 829 year: 2013 ident: 6438_CR2 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4145 – volume: 13 start-page: 1111 year: 2005 ident: 6438_CR17 publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2004.11.028 – volume: 22 start-page: 3099 year: 1973 ident: 6438_CR39 publication-title: Biochem. Pharmacol. doi: 10.1016/0006-2952(73)90196-2 – volume: 7 start-page: 6006 year: 2014 ident: 6438_CR18 publication-title: Int J Clin Exp Pathol – volume: 447 start-page: 784 year: 2004 ident: 6438_CR25 publication-title: Pflugers Arch. doi: 10.1007/s00424-003-1117-9 – volume: 3 start-page: 1 year: 2016 ident: 6438_CR19 publication-title: Med. Express doi: 10.5935/MedicalExpress.2016.06.05 – volume: 324 start-page: 1029 year: 2009 ident: 6438_CR3 publication-title: Science (80-.) doi: 10.1126/science.1160809 – volume: 7 start-page: 274ra17 year: 2015 ident: 6438_CR10 publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aaa1009 – volume: 4 start-page: 281 year: 2013 ident: 6438_CR32 publication-title: Ther. Deliv. doi: 10.4155/tde.12.165 – volume: 8 start-page: 2063 year: 2013 ident: 6438_CR16 publication-title: ACS Chem. Biol. doi: 10.1021/cb400258d – volume: 35 start-page: 3201 year: 2016 ident: 6438_CR8 publication-title: Oncogene doi: 10.1038/onc.2015.381 – volume: 136 start-page: 1722 year: 2014 ident: 6438_CR15 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja411138s – volume: 25 start-page: 113 year: 2015 ident: 6438_CR24 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2014.10.098 – volume: 1514 start-page: 291 year: 2001 ident: 6438_CR27 publication-title: Biochim. Biophys. Acta doi: 10.1016/S0005-2736(01)00384-4 – volume: 46 start-page: 2463 year: 2014 ident: 6438_CR12 publication-title: Amino Acids doi: 10.1007/s00726-014-1808-x – volume: 53 start-page: 1253 year: 2012 ident: 6438_CR35 publication-title: J. Nucl. Med. doi: 10.2967/jnumed.112.103069 – volume: 275 start-page: 22790 year: 2000 ident: 6438_CR26 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M002965200 – volume: 53 start-page: 1616 year: 2012 ident: 6438_CR31 publication-title: J. Nucl. Med. doi: 10.2967/jnumed.111.101279 – volume: 42 start-page: 1141 year: 2009 ident: 6438_CR38 publication-title: Acc. Chem. Res. doi: 10.1021/ar900035f – volume: 119 start-page: 9931 year: 1997 ident: 6438_CR21 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja972089n – volume: 382 start-page: 27 year: 2004 ident: 6438_CR20 publication-title: Biochem. J. doi: 10.1042/BJ20040487 – volume: 73 start-page: 2184 year: 1999 ident: 6438_CR22 publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1999.02184.x – volume: 11 start-page: 1785 year: 2010 ident: 6438_CR14 publication-title: Biomacromolecules doi: 10.1021/bm100248e – volume: 283 start-page: G1062 year: 2002 ident: 6438_CR6 publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. doi: 10.1152/ajpgi.00031.2002 – volume: 11 start-page: 85 year: 2011 ident: 6438_CR1 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2981 – volume: 236 start-page: 278 year: 2015 ident: 6438_CR7 publication-title: J. Pathol. doi: 10.1002/path.4518 – ident: 6438_CR36 – volume: 557 start-page: 747 year: 2004 ident: 6438_CR29 publication-title: J. Physiol. doi: 10.1113/jphysiol.2004.062521 – volume: 106 start-page: 279 year: 2015 ident: 6438_CR34 publication-title: Cancer Sci. doi: 10.1111/cas.12602 – volume: 496 start-page: 101 year: 2013 ident: 6438_CR5 publication-title: Nature doi: 10.1038/nature12040 – volume: 135 start-page: 1060 year: 2014 ident: 6438_CR9 publication-title: Int. J. cancer doi: 10.1002/ijc.28749 |
| SSID | ssj0000529419 |
| Score | 2.306229 |
| Snippet | Increased glutamine uptake toward the elevated glutaminolysis is one of the hallmarks of tumour cells. This aberrant glutamine metabolism has recently... Abstract Increased glutamine uptake toward the elevated glutaminolysis is one of the hallmarks of tumour cells. This aberrant glutamine metabolism has recently... |
| SourceID | doaj pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 6077 |
| SubjectTerms | 13/31 140/131 631/92/577 639/301/54/990 639/638/455/954 Affinity Glutamine Humanities and Social Sciences Metabolism multidisciplinary Polymers Science Science (multidisciplinary) Tumors |
| SummonAdditionalLinks | – databaseName: DOAJ Open Access Full Text dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlUOil9F23SVGht9ZEsl7WMUmbhkJLIQnkJvSkC4437HoPvvWnZ2R7t7t9XnoyeCQsax4aSTPfIPSGiNpHJmzpouQlVxZ0zlNX5jIvPAmlwT7kaIsv8uySf7oSV1ulvnJM2AgPPE7coZTCEcecdarOUCZOcloHF6LzgYrksvUlmmxtpkZU70pzqqcsGcLqwyWsVDmbjOZoLw5a3u-sRANg_--8zF-DJX-6MR0WotMH6P7kQeKjceQP0Z3YPkJ3x5qS_WP0fQthEF-sYGe_wCexacrj2ZDAgs_7Fpw-6Iy_zps-H1vjfBiLz3MoO9DfwzPiH6DnQF_zMIax6ZGLC6B3-CPIrb2Gz-HPsQNxambL6yfo8vTDxclZOZVZKD14H11Z2eSI8N4LcB0diclKzbzwNfcVF1apoAjnwenEePApgcMXgvZRgW2iVnr2FO218zY-R1h5GWuWVHIycA87PwYs4p4FzXVdRVIgup5y4ycM8lwKozHDXTirzcgmA2wyA5tMX6C3mz43IwLHX1sfZ05uWmb07OEFyJSZZMr8S6YKtL-WAzOp9NLkxEqqmNTwF683ZFDGfMNi2zhf5TZgHnPSDS3Qs1FsNiOBrWmlpVIFUjsCtTPUXUo7-zYAfoNXq6WGnu_Worc1rD9OxYv_MRUv0b1q0BkF9nQf7XWLVTwAN6xzrwaNuwWw-jJ4 priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZKKyQuiDeBgozEDaIm8Ss-INQtLRUSq4q2Um9W_AislCZlN3vIjZ_O2Hm0y6OnSDu24s18Mx57Xgi9TVhuHGFFrB2nMRUFyJxJdezbvNCSCQn6wUdbzPnxOf1ywS620HzMhfFhlaNODIraNsbfke_5vLZUEDjMfbz6GfuuUd67OrbQKIbWCvZDKDF2B-2ASs4B9zuzw_nJt-nWxfu1aCqH7JmE5Hsr2MF8llnqo8AoSH-3sUOFQv7_sj7_DqL8w5MaNqijB-j-YFni_R4KD9GWqx-hu32vye4x-nWj8iA-W8OJf4kPXFXFs0VIbMGnXQ3GIEzGJ03V-ets7C9p8akPcQf6J3g6fF0MHegjb53th-5rtwR6iz8DnotLeB3-6lqAWbVYXT5B50eHZwfH8dB-ITZglbRxVpQ6YcYYBialTlxZcEkMMzk1GWWFEFYklFotS0KtKUswBK2VxgnQWWnBDXmKtuumds8RFoa7nJSi1NxSAydCkrKSGmIllXnmkgil4ydXZqhN7ltkVCr4yEmuejYpYJMKbFJdhN5Nc676yhy3jp55Tk4jfVXt8EOz_K4GIVWcM51oogstcl82R3Oa5lZbp42FBesI7Y44UIOor9Q1MCP0ZiKDkHrPS1G7Zu3HgNr0yThphJ71sJlWAkfWTHIhIiQ2ALWx1E1KvfgRCoED1CWXMPP9CL0by_rvp3hx-794ie5lQRoEaNBdtN0u1-4VGF6tfj1I029Efi9h priority: 102 providerName: ProQuest – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELbKVkhcEG8CBRmJG0Qk8Ss-bgulWgmEtK3Um-VXYKU0i3azh9z46YydB10oSJwi7YyV2czDY3vmM0KvM1ZaT5hOjec0pUKDz9ncpOGaF1oxISE-hGqLz_zsgi4u2eUBKsZemFi0HyEtY5geq8PebWGiCc1geSjWouCk3S10WML0V8zQ4Xy-WC6mnZVwdkVzOXTIZKS8YfDeLBTB-m_KMP8slPzttDROQqf30N0he8TzXt776MA3D9Dt_j7J7iH6cQ1dEJ_vYFW_wSe-rtPjVWxewcuugYQPBuMv67oLW9Y4bMTiZShjB_p7eHr8C_Ac6KP-vOtZ58ZvgN7ij2Cz-gpehz_5FkypXm2vHqGL0w_nJ2fpcMVCaiHzaNNCVyZj1loGaaPJfKW5JJbZktqCMi2EExmlzsiKUGerCpI956T1AuJSrrklj9GsWTf-KcLCcl-SSlSGO2ph1UdyVlFLnKSyLHyWoHz85MoO-OPhGoxaxXNwUqpeTQrUpKKaVJegN9OY7z36xj-5j4MmJ86AnB1_WG--qsGSFOfMZIYYbUQZoHEMp3npjPPGOhDYJOhotAM1uPNWhabKXBAu4V-8msjgiOF0RTd-vQs8EBpDw02eoCe92UySwLK0kFyIBIk9g9oTdZ_SrL5FsG_IaCWXMPLtaHrXxPrrp3j2f-zP0Z0ieoeAqHmEZu1m519AstWal4N3_QS--iiD priority: 102 providerName: Springer Nature |
| Title | Engineering Tumour Cell-Binding Synthetic Polymers with Sensing Dense Transporters Associated with Aberrant Glutamine Metabolism |
| URI | https://link.springer.com/article/10.1038/s41598-017-06438-y https://www.ncbi.nlm.nih.gov/pubmed/28729677 https://www.proquest.com/docview/1956173690 https://www.proquest.com/docview/1922506861 https://pubmed.ncbi.nlm.nih.gov/PMC5519697 https://doaj.org/article/665b0b3bab784948b6418dbdebcd15fb |
| Volume | 7 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELb2ISQuiDeBpTISNwjk4Ud8QKgtu6wq7WpFt1JvUfwIVMqmu2kqkRs_nbGTlC0UDpwiZWzF8czYnx_zDUKvA5ooE9PMl4YRn_AMfE6F0rdpXkhOuYDxwd62OGenMzKZ0_ke6tMddR242rm0s_mkZlXx7vtN8xEc_kMbMp68X8EkZAPFQnuRi4ADN_voEGYmZhdjZx3cb7m-I0FC0cXO7K5q2YETQJyM862pyjH674Khf96m_O1I1c1UJ_fRvQ5i4mFrEw_Qnikfojtt0snmEfpxi4IQX65h6V_hsSkKf7RwES542pSACqEyvlgWjd3Xxna3Fk_tXXeQf4Knwb9Y0UHeK9notuhQmgrkNf4Mhp1dwefwmanB3orF6uoxmp0cX45P_S4Pg68AntR-lOUyoEopCthSBibPmIgVVQlREaEZ55oHhGgp8pholeeACLUWynAYvMKMqfgJOiiXpXmGMFfMJHHOc8k0UbA0jEOaExVrQUQSmcBDYd_lqepIym2ujCJ1h-VxkrYaS0FjqdNY2njozabOdUvR8c_SI6vJTUlLr-1eLKuvaeetKWNUBjKWmeSJ5c-RjISJltpIpaHB0kNHvR2kvcmmNvIy5DET8BevNmLwVnsEk5VmubZlYPy0UTmhh562ZrNpSW92HuJbBrXV1G1JufjmGMEB9gomoObb3vRuNeuvXfH8vz_0At2NnM9wGGWP0EFdrc1LAGe1HKB9PucDdDgcTqYTeI6Ozy--wNsxGw_chsfA-eRPCOo_jw |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbtQw9KlMheCC2AkUMBKcIGoSO3ZyqFCnC1PajiraSr258RIYaSZTZhHKjS_j23jOMu2w9NZTpLznxMlb_Oy3AbwN4kRbGme-spz5TGQoczpUvmvzwvJYpKgfXLRFn_dO2eez-GwFfrW5MC6sstWJlaI2Y-3OyNddXlsoKG7mPl58913XKOddbVtoZE1rBbNRlRhrEjv2bfkDt3DTjb1tpPe7KNrdOdnq-U2XAV_j4jvzoyxXQay1jtFyUoHNM55SHeuE6YjFmRBGBIwZleaUGZ3naO8Yk2orUDTDjGuKz70Fq8xluHZgtbvTP_qyOOVxfjQWpk22TkCT9SmumC6rLXRRZwy1Tbm0IlaNA_5l7f4dtPmH57ZaEHfvw73GkiWbNes9gBVbPITbdW_L8hH8vFLpkJzMR4hOtuxw6HcHVSINOS4LND5xMDkaD0t3fE7coTA5diH1CN_GqyWXxdcR3vKSNTXqprIThM_IJ5SfbISvI4d2hmw9HExHj-H0RgjxBDrFuLDPgAjNbUJzkStumMYdKA3jnGlqUpYmkQ08CNtfLnVTC9215BjKyidPE1mTSSKZZEUmWXrwfjHmoq4Eci1211FygemqeFc3xpOvslEKkvNYBYqqTInElelRnIWJUcYqbXDCyoO1lg9ko1qm8lIQPHizAKNScJ6erLDjucNBNe2Sf0IPntZss5gJbpGjlAvhgVhiqKWpLkOKwbeq8DiKVspTHPmhZb0r0_rvr3h-_Ve8hju9k8MDebDX338Bd6NKMgRq7zXozCZz-xKNvpl61UgWgfObFubftQdtjA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbtNA9KmkAnFB7BgKDBKcwIqX8Yx9qFDTNLQUooi2Um9Tz2KIlNgli5BvfB9fxRsvacPSW0-R8t4kY7915m0Ar70oViaMUlcaRl3KU5Q55UvXjnmhWcQT1A8222LI9k_ox9PodAN-tbUwNq2y1YmVotaFsnfkXVvX5vMQD3PdrEmLGPUH78-_u3aClI20tuM00mbMgt6u2o01RR6HpvyBx7n59kEfaf8mCAZ7x7v7bjNxwFVoiBdukGbSi5RSEXpR0jNZypJQRSqmKqBRyrnmHqVaJllItcoy9H20TpThKKZ-ylSIv3sDNjlaSdqBzd7ecPRldeNjY2rUT5rKHS-Mu3O0nrbCzbcZaBQ1T7lmHashAv_yfP9O4PwjilsZx8FduNN4tWSnZsN7sGHy-3CznnNZPoCfl7oekuPlFNHJrplM3N64KqohR2WOjiguJqNiUtqrdGIviMmRTa9HeB8_DbloxI7wlq-MrlF3pJkhfEE-oCylU_w78tkskMUn4_n0IZxcCyEeQScvcvMECFfMxGHGM8k0VXgaDf0ooyrUCU3iwHgO-O0rF6rpi27Hc0xEFZ8PY1GTSSCZREUmUTrwdrXmvO4KciV2z1JyhWk7eldfFLOvolEQgrFIejKUqeSxbdkjGfVjLbWRSuOGpQNbLR-IRs3MxYVQOPBqBUYFYaM-aW6KpcVBlW0LgXwHHtdss9oJHpeDhHHuAF9jqLWtrkPy8beqCTmKVsISXPmuZb1L2_rvq3h69VO8hFso1OLTwfDwGdwOKsHgqMi3oLOYLc1z9P8W8kUjWATOrluWfwN4gnG4 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Engineering+Tumour+Cell-Binding+Synthetic+Polymers+with+Sensing+Dense+Transporters+Associated+with+Aberrant+Glutamine+Metabolism&rft.jtitle=Scientific+reports&rft.au=Yamada%2C+Naoki&rft.au=Honda%2C+Yuto&rft.au=Takemoto%2C+Hiroyasu&rft.au=Nomoto%2C+Takahiro&rft.date=2017-07-20&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=7&rft_id=info:doi/10.1038%2Fs41598-017-06438-y&rft_id=info%3Apmid%2F28729677&rft.externalDocID=PMC5519697 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |